Purchase Order 75N93024P00937
- Not listed
- Active Motif, Inc., doing business as Active Motif, has been awarded a $13,080 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNA and end-to-end RNA sequencing services. The one-year contract, which runs from October 2023 through October 2024, will support NIAID's research efforts through the delivery of RNA and sequencing analysis services. Active Motif will perform the work as the prime contractor...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Active Motif, Inc., a small disadvantaged business manufacturer of goods, to provide custom DNA sequencing services. The contract is for 3 samples of "CBLX DISORDERQUANTITY" at $4,740.00 and 1 control sample at $1,750.00, for a total potential value of $15,970.00. The contract does not have a...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $13,080 firm fixed price purchase order to Active Motif, Inc. for an end-to-end RNA-seq service including bioinformatic analysis and custom assay involving RNA-seq sample submission in RLT buffer. As the prime contractor, Active Motif will perform the work out of its facilities in Carlsbad, California under a one-year period of performance through September 2024. No subcontractors or set aside...
- This is a firm fixed price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services. The contract, valued at $5,470.00, was set aside for a small disadvantaged business, Active Motif, Inc. The contract covers the provision of unspecified products or services related to the agency's mission, which likely includes biomedical research. Active Motif is a leading provider of tools and...
- This is a $7,135 firm fixed price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Active Motif, Inc., a small disadvantaged business. The contract is for ChIP-seq and RNA-seq analysis to support gene expression studies. It does not have a set-aside designation. Active Motif has a history of providing genomic sequencing and bioinformatics services to NIH and other federal agencies through both...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $61,975.00 firm fixed price purchase order contract to Active Motif, Inc. for Chromatin Immunoprecipitation (ChIP) sequence analysis services. This sole source contract was awarded without a set-aside designation under the authority of 41 U.S.C. 1901(e)(2) as only Active Motif could provide the required services. The contract supports the...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Active Motif, Inc. for $37,800.00 on September 12, 2017, under a total small business set-aside. The order covers FactorPath ChIP-seq and HCF1 ChIP-seq analysis for four mouse fibroblast cell lines. Work is performed in Carlsbad, California. The purchase order is firm fixed price with an ultimate completion date of October 12, 2017.</p>
- This federal contract award, valued at $31,900.00, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Active Motif, Inc., a small disadvantaged business. The contract provides "FACTOR PATH ANALYSIS SERVICE" with a completion date of March 29, 2023. The work is related to a pre-solicitation opportunity focused on using ChIP-seq (Chromatin Immunoprecipitation Sequencing) and other genomic research techniques to map cell signaling pathways...
- Active Motif, Inc. was awarded a $16,790 firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases to provide biological materials. The contract has a period of performance of November 2, 2023 through November 1, 2024. As the prime contractor, Active Motif will deliver the requested products to the NIH/NIAMS for use in advancing the agency's biomedical research mission. No subcontractors or set aside...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $309,750 firm fixed price purchase order to Active Motif, Inc. for FactorPath ChIP-Seq, HistonePath and input sequencing services. The solicitation sought these epigenetic profiling services to characterize patient-derived dermal fibroblasts and determine the impact of ancestry, sex, and age on induced pluripotent stem cell reprogramming efficiency. Active Motif...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $14,425.00 firm fixed price purchase order to Active Motif, Inc. for sequencing services. The contract has an ultimate completion date of November 2, 2024 and was not set aside for any specific business type. Active Motif, Inc. is a small disadvantaged business that provides innovative tools, antibodies, and sequencing services to support biomedical research efforts in areas like gene expression, epigenetics, and disease studies. The company has a history of federal contract awards, primarily from NIH and its institutes, covering a range of genomic sequencing and bioinformatic analysis services. In addition to this contract, Active Motif received a $314,262 grant from the NIH National Institute on Aging to support the development and validation of their Microscopic Imaging of Epigenetic Age (MIEPIage) platform, a novel single-cell method to quantify epigenetic changes and detect cellular rejuvenation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 7/31/24 |